Promising gene therapy against hemophilia rejected by FDA
BioMarin had gone so far as to give its hemophilia A gene therapy a name. Now it will have to deliver more data to the FDA.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Ron Leuty Source Type: news